PSB1_HUMAN
ID PSB1_HUMAN Reviewed; 241 AA.
AC P20618; B5BU76; Q9BWA8;
DT 01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT 01-MAY-1992, sequence version 2.
DT 03-AUG-2022, entry version 226.
DE RecName: Full=Proteasome subunit beta type-1;
DE AltName: Full=Macropain subunit C5;
DE AltName: Full=Multicatalytic endopeptidase complex subunit C5;
DE AltName: Full=Proteasome component C5;
DE AltName: Full=Proteasome gamma chain;
DE Flags: Precursor;
GN Name=PSMB1; Synonyms=PSC5;
OS Homo sapiens (Human).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC Homo.
OX NCBI_TaxID=9606;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RX PubMed=2025653; DOI=10.1016/0167-4781(91)90090-9;
RA Tamura T., Lee D.H., Osaka F., Fujiwara T., Shin S., Chung C.H., Tanaka K.,
RA Ichihara A.;
RT "Molecular cloning and sequence analysis of cDNAs for five major subunits
RT of human proteasomes (multi-catalytic proteinase complexes).";
RL Biochim. Biophys. Acta 1089:95-102(1991).
RN [2]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA Phelan M., Farmer A.;
RT "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN [3]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX PubMed=19054851; DOI=10.1038/nmeth.1273;
RA Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H., Maruyama Y.,
RA Matsuo K., Minami K., Mitsubori M., Mori M., Morishita R., Murase A.,
RA Nishikawa A., Nishikawa S., Okamoto T., Sakagami N., Sakamoto Y.,
RA Sasaki Y., Seki T., Sono S., Sugiyama A., Sumiya T., Takayama T.,
RA Takayama Y., Takeda H., Togashi T., Yahata K., Yamada H., Yanagisawa Y.,
RA Endo Y., Imamoto F., Kisu Y., Tanaka S., Isogai T., Imai J., Watanabe S.,
RA Nomura N.;
RT "Human protein factory for converting the transcriptome into an in vitro-
RT expressed proteome.";
RL Nat. Methods 5:1011-1017(2008).
RN [4]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX PubMed=14574404; DOI=10.1038/nature02055;
RA Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA Rogers J., Beck S.;
RT "The DNA sequence and analysis of human chromosome 6.";
RL Nature 425:805-811(2003).
RN [5]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-11.
RC TISSUE=Brain, and Lung;
RX PubMed=15489334; DOI=10.1101/gr.2596504;
RG The MGC Project Team;
RT "The status, quality, and expansion of the NIH full-length cDNA project:
RT the Mammalian Gene Collection (MGC).";
RL Genome Res. 14:2121-2127(2004).
RN [6]
RP PROTEIN SEQUENCE OF 29-52.
RX PubMed=2306472; DOI=10.1016/0167-4838(90)90165-c;
RA Lee L.W., Moomaw C.R., Orth K., McGuire M.J., DeMartino G.N.,
RA Slaughter C.A.;
RT "Relationships among the subunits of the high molecular weight proteinase,
RT macropain (proteasome).";
RL Biochim. Biophys. Acta 1037:178-185(1990).
RN [7]
RP FUNCTION IN ANTIGEN PRESENTATION.
RX PubMed=8610016; DOI=10.1038/381166a0;
RA Groettrup M., Soza A., Eggers M., Kuehn L., Dick T.P., Schild H.,
RA Rammensee H.G., Koszinowski U.H., Kloetzel P.M.;
RT "A role for the proteasome regulator PA28alpha in antigen presentation.";
RL Nature 381:166-168(1996).
RN [8]
RP SUBCELLULAR LOCATION.
RX PubMed=12181345; DOI=10.1091/mbc.e02-03-0122;
RA Lafarga M., Berciano M.T., Pena E., Mayo I., Castano J.G., Bohmann D.,
RA Rodrigues J.P., Tavanez J.P., Carmo-Fonseca M.;
RT "Clastosome: a subtype of nuclear body enriched in 19S and 20S proteasomes,
RT ubiquitin, and protein substrates of proteasome.";
RL Mol. Biol. Cell 13:2771-2782(2002).
RN [9]
RP INTERACTION WITH HIV-1 TAT (MICROBIAL INFECTION).
RX PubMed=14550573; DOI=10.1016/s0014-5793(03)01025-1;
RA Apcher G.S., Heink S., Zantopf D., Kloetzel P.-M., Schmid H.-P.,
RA Mayer R.J., Krueger E.;
RT "Human immunodeficiency virus-1 Tat protein interacts with distinct
RT proteasomal alpha and beta subunits.";
RL FEBS Lett. 553:200-204(2003).
RN [10]
RP INTERACTION WITH SERPINB2.
RX PubMed=14732874; DOI=10.1093/abbs/36.1.42;
RA Fan J., Zhang Y.Q., Li P., Hou M., Tan L., Wang X., Zhu Y.S.;
RT "Interaction of plasminogen activator inhibitor-2 and proteasome subunit,
RT beta type 1.";
RL Acta Biochim. Biophys. Sin. 36:42-46(2004).
RN [11]
RP FUNCTION.
RX PubMed=15244466; DOI=10.1021/bm049957a;
RA Yano M., Koumoto Y., Kanesaki Y., Wu X., Kido H.;
RT "20S proteasome prevents aggregation of heat-denatured proteins without
RT PA700 regulatory subcomplex like a molecular chaperone.";
RL Biomacromolecules 5:1465-1469(2004).
RN [12]
RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC TISSUE=Embryonic kidney;
RX PubMed=17323924; DOI=10.1021/bi061994u;
RA Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.;
RT "Mass spectrometric characterization of the affinity-purified human 26S
RT proteasome complex.";
RL Biochemistry 46:3553-3565(2007).
RN [13]
RP ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-204, AND IDENTIFICATION BY MASS
RP SPECTROMETRY [LARGE SCALE ANALYSIS].
RX PubMed=19608861; DOI=10.1126/science.1175371;
RA Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA Olsen J.V., Mann M.;
RT "Lysine acetylation targets protein complexes and co-regulates major
RT cellular functions.";
RL Science 325:834-840(2009).
RN [14]
RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA Bennett K.L., Superti-Furga G., Colinge J.;
RT "Initial characterization of the human central proteome.";
RL BMC Syst. Biol. 5:17-17(2011).
RN [15]
RP ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP SPECTROMETRY [LARGE SCALE ANALYSIS].
RX PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT "N-terminal acetylome analyses and functional insights of the N-terminal
RT acetyltransferase NatB.";
RL Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN [16]
RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62; SER-68 AND SER-162, AND
RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC TISSUE=Cervix carcinoma, and Erythroleukemia;
RX PubMed=23186163; DOI=10.1021/pr300630k;
RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA Mohammed S.;
RT "Toward a comprehensive characterization of a human cancer cell
RT phosphoproteome.";
RL J. Proteome Res. 12:260-271(2013).
RN [17]
RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX PubMed=25944712; DOI=10.1002/pmic.201400617;
RA Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT "N-terminome analysis of the human mitochondrial proteome.";
RL Proteomics 15:2519-2524(2015).
RN [18]
RP FUNCTION.
RX PubMed=27176742; DOI=10.1515/hsz-2016-0176;
RA Rut W., Drag M.;
RT "Human 20S proteasome activity towards fluorogenic peptides of various
RT chain lengths.";
RL Biol. Chem. 397:921-926(2016).
RN [19]
RP STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS) OF 35-239, AND SUBUNIT.
RX PubMed=26133119; DOI=10.1038/ncomms8573;
RA da Fonseca P.C., Morris E.P.;
RT "Cryo-EM reveals the conformation of a substrate analogue in the human 20S
RT proteasome core.";
RL Nat. Commun. 6:7573-7573(2015).
RN [20]
RP X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 35-236, AND SUBUNIT.
RX PubMed=25599644; DOI=10.1016/j.str.2014.11.017;
RA Harshbarger W., Miller C., Diedrich C., Sacchettini J.;
RT "Crystal structure of the human 20S proteasome in complex with
RT carfilzomib.";
RL Structure 23:418-424(2015).
RN [21]
RP STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS), AND SUBUNIT.
RX PubMed=27428775; DOI=10.1038/nsmb.3273;
RA Huang X., Luan B., Wu J., Shi Y.;
RT "An atomic structure of the human 26S proteasome.";
RL Nat. Struct. Mol. Biol. 23:778-785(2016).
RN [22]
RP STRUCTURE BY ELECTRON MICROSCOPY (4.02 ANGSTROMS), AND SUBUNIT.
RX PubMed=27342858; DOI=10.1073/pnas.1608050113;
RA Schweitzer A., Aufderheide A., Rudack T., Beck F., Pfeifer G.,
RA Plitzko J.M., Sakata E., Schulten K., Foerster F., Baumeister W.;
RT "Structure of the human 26S proteasome at a resolution of 3.9 Aa.";
RL Proc. Natl. Acad. Sci. U.S.A. 113:7816-7821(2016).
RN [23]
RP X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 35-239, AND SUBUNIT.
RX PubMed=27493187; DOI=10.1126/science.aaf8993;
RA Schrader J., Henneberg F., Mata R.A., Tittmann K., Schneider T.R.,
RA Stark H., Bourenkov G., Chari A.;
RT "The inhibition mechanism of human 20S proteasomes enables next-generation
RT inhibitor design.";
RL Science 353:594-598(2016).
RN [24]
RP STRUCTURE BY ELECTRON MICROSCOPY (2.80 ANGSTROMS) IN COMPLEX WITH AKIRIN2,
RP SUBUNIT, AND SUBCELLULAR LOCATION.
RX PubMed=34711951; DOI=10.1038/s41586-021-04035-8;
RA de Almeida M., Hinterndorfer M., Brunner H., Grishkovskaya I., Singh K.,
RA Schleiffer A., Jude J., Deswal S., Kalis R., Vunjak M., Lendl T., Imre R.,
RA Roitinger E., Neumann T., Kandolf S., Schutzbier M., Mechtler K.,
RA Versteeg G.A., Haselbach D., Zuber J.;
RT "AKIRIN2 controls the nuclear import of proteasomes in vertebrates.";
RL Nature 599:491-496(2021).
CC -!- FUNCTION: Non-catalytic component of the 20S core proteasome complex
CC involved in the proteolytic degradation of most intracellular proteins.
CC This complex plays numerous essential roles within the cell by
CC associating with different regulatory particles. Associated with two
CC 19S regulatory particles, forms the 26S proteasome and thus
CC participates in the ATP-dependent degradation of ubiquitinated
CC proteins. The 26S proteasome plays a key role in the maintenance of
CC protein homeostasis by removing misfolded or damaged proteins that
CC could impair cellular functions, and by removing proteins whose
CC functions are no longer required. Associated with the PA200 or PA28,
CC the 20S proteasome mediates ubiquitin-independent protein degradation.
CC This type of proteolysis is required in several pathways including
CC spermatogenesis (20S-PA200 complex) or generation of a subset of MHC
CC class I-presented antigenic peptides (20S-PA28 complex).
CC {ECO:0000269|PubMed:15244466, ECO:0000269|PubMed:27176742,
CC ECO:0000269|PubMed:8610016}.
CC -!- SUBUNIT: The 26S proteasome consists of a 20S proteasome core and two
CC 19S regulatory subunits (PubMed:25599644, PubMed:26133119,
CC PubMed:27342858, PubMed:27428775, PubMed:27493187, PubMed:34711951).
CC The 20S proteasome core is a barrel-shaped complex made of 28 subunits
CC that are arranged in four stacked rings (PubMed:25599644,
CC PubMed:26133119, PubMed:27342858, PubMed:27428775, PubMed:27493187,
CC PubMed:34711951). The two outer rings are each formed by seven alpha
CC subunits, and the two inner rings are formed by seven beta subunits
CC (PubMed:25599644, PubMed:26133119, PubMed:27342858, PubMed:27428775,
CC PubMed:27493187, PubMed:34711951). The proteolytic activity is exerted
CC by three beta-subunits PSMB5, PSMB6 and PSMB7 (PubMed:25599644,
CC PubMed:26133119, PubMed:27342858, PubMed:27428775, PubMed:27493187,
CC PubMed:34711951). Interacts with SERPINB2 (PubMed:14732874). Interacts
CC with RFPL4A (By similarity). {ECO:0000250|UniProtKB:O09061,
CC ECO:0000269|PubMed:14732874, ECO:0000269|PubMed:25599644,
CC ECO:0000269|PubMed:26133119, ECO:0000269|PubMed:27342858,
CC ECO:0000269|PubMed:27428775, ECO:0000269|PubMed:27493187,
CC ECO:0000269|PubMed:34711951}.
CC -!- SUBUNIT: (Microbial infection) Interacts with HIV-1 protein Tat.
CC {ECO:0000269|PubMed:14550573}.
CC -!- INTERACTION:
CC P20618; O95994: AGR2; NbExp=3; IntAct=EBI-372273, EBI-712648;
CC P20618; Q9NZD4: AHSP; NbExp=3; IntAct=EBI-372273, EBI-720250;
CC P20618; A0A087WVE9: ARNT2; NbExp=3; IntAct=EBI-372273, EBI-12808086;
CC P20618; Q8N7W2-2: BEND7; NbExp=3; IntAct=EBI-372273, EBI-10181188;
CC P20618; Q96CA5: BIRC7; NbExp=5; IntAct=EBI-372273, EBI-517623;
CC P20618; Q9NP55: BPIFA1; NbExp=3; IntAct=EBI-372273, EBI-953896;
CC P20618; Q13555-5: CAMK2G; NbExp=3; IntAct=EBI-372273, EBI-12020154;
CC P20618; Q9NUG4: CCM2L; NbExp=3; IntAct=EBI-372273, EBI-350645;
CC P20618; O60729: CDC14B; NbExp=3; IntAct=EBI-372273, EBI-970231;
CC P20618; Q16740: CLPP; NbExp=3; IntAct=EBI-372273, EBI-1056029;
CC P20618; Q9Y2V7: COG6; NbExp=3; IntAct=EBI-372273, EBI-3866319;
CC P20618; P78358: CTAG1B; NbExp=3; IntAct=EBI-372273, EBI-1188472;
CC P20618; Q9UIA0: CYTH4; NbExp=3; IntAct=EBI-372273, EBI-11521003;
CC P20618; Q8WTU0: DDI1; NbExp=3; IntAct=EBI-372273, EBI-748248;
CC P20618; Q96C01: FAM136A; NbExp=3; IntAct=EBI-372273, EBI-373319;
CC P20618; Q9Y247: FAM50B; NbExp=3; IntAct=EBI-372273, EBI-742802;
CC P20618; Q8TAE8: GADD45GIP1; NbExp=3; IntAct=EBI-372273, EBI-372506;
CC P20618; O14893: GEMIN2; NbExp=3; IntAct=EBI-372273, EBI-443648;
CC P20618; P57678: GEMIN4; NbExp=3; IntAct=EBI-372273, EBI-356700;
CC P20618; Q86WP2: GPBP1; NbExp=3; IntAct=EBI-372273, EBI-2349758;
CC P20618; Q4V328: GRIPAP1; NbExp=3; IntAct=EBI-372273, EBI-717919;
CC P20618; Q9BX10: GTPBP2; NbExp=3; IntAct=EBI-372273, EBI-6115579;
CC P20618; Q9NP66: HMG20A; NbExp=3; IntAct=EBI-372273, EBI-740641;
CC P20618; P49639: HOXA1; NbExp=3; IntAct=EBI-372273, EBI-740785;
CC P20618; P42858: HTT; NbExp=7; IntAct=EBI-372273, EBI-466029;
CC P20618; Q9P2X3: IMPACT; NbExp=3; IntAct=EBI-372273, EBI-2857352;
CC P20618; Q96N16: JAKMIP1; NbExp=3; IntAct=EBI-372273, EBI-2680803;
CC P20618; Q9H079: KATNBL1; NbExp=5; IntAct=EBI-372273, EBI-715394;
CC P20618; Q7Z7F0-4: KHDC4; NbExp=3; IntAct=EBI-372273, EBI-9089060;
CC P20618; Q9BVG8: KIFC3; NbExp=4; IntAct=EBI-372273, EBI-2125614;
CC P20618; Q9BVG8-5: KIFC3; NbExp=3; IntAct=EBI-372273, EBI-14069005;
CC P20618; A1A4E9: KRT13; NbExp=3; IntAct=EBI-372273, EBI-10171552;
CC P20618; P19012: KRT15; NbExp=7; IntAct=EBI-372273, EBI-739566;
CC P20618; Q15323: KRT31; NbExp=3; IntAct=EBI-372273, EBI-948001;
CC P20618; O76011: KRT34; NbExp=3; IntAct=EBI-372273, EBI-1047093;
CC P20618; O76013-2: KRT36; NbExp=3; IntAct=EBI-372273, EBI-11958506;
CC P20618; Q6A162: KRT40; NbExp=3; IntAct=EBI-372273, EBI-10171697;
CC P20618; Q3LI76: KRTAP15-1; NbExp=3; IntAct=EBI-372273, EBI-11992140;
CC P20618; Q8IUB9: KRTAP19-1; NbExp=3; IntAct=EBI-372273, EBI-12811111;
CC P20618; Q3SYF9: KRTAP19-7; NbExp=3; IntAct=EBI-372273, EBI-10241353;
CC P20618; Q8IUC3: KRTAP7-1; NbExp=3; IntAct=EBI-372273, EBI-18394498;
CC P20618; Q5T751: LCE1C; NbExp=3; IntAct=EBI-372273, EBI-12224199;
CC P20618; Q5T754: LCE1F; NbExp=3; IntAct=EBI-372273, EBI-11958008;
CC P20618; O43679: LDB2; NbExp=3; IntAct=EBI-372273, EBI-2865580;
CC P20618; Q96BZ8: LENG1; NbExp=3; IntAct=EBI-372273, EBI-726510;
CC P20618; Q9UBR4-2: LHX3; NbExp=3; IntAct=EBI-372273, EBI-12039345;
CC P20618; Q9HAP6: LIN7B; NbExp=3; IntAct=EBI-372273, EBI-821335;
CC P20618; P25800: LMO1; NbExp=3; IntAct=EBI-372273, EBI-8639312;
CC P20618; Q9NQ48: LZTFL1; NbExp=3; IntAct=EBI-372273, EBI-2824799;
CC P20618; Q9UPY8: MAPRE3; NbExp=3; IntAct=EBI-372273, EBI-726739;
CC P20618; Q13064: MKRN3; NbExp=3; IntAct=EBI-372273, EBI-2340269;
CC P20618; Q8NB16-2: MLKL; NbExp=3; IntAct=EBI-372273, EBI-19046912;
CC P20618; Q6NTE8: MRNIP; NbExp=3; IntAct=EBI-372273, EBI-2857471;
CC P20618; Q5JR59-3: MTUS2; NbExp=3; IntAct=EBI-372273, EBI-11522433;
CC P20618; P60323-2: NANOS3; NbExp=3; IntAct=EBI-372273, EBI-18012223;
CC P20618; P49821: NDUFV1; NbExp=3; IntAct=EBI-372273, EBI-748312;
CC P20618; O00746: NME4; NbExp=3; IntAct=EBI-372273, EBI-744871;
CC P20618; O43482: OIP5; NbExp=3; IntAct=EBI-372273, EBI-536879;
CC P20618; Q6GQQ9: OTUD7B; NbExp=3; IntAct=EBI-372273, EBI-527784;
CC P20618; P78356-2: PIP4K2B; NbExp=3; IntAct=EBI-372273, EBI-11532361;
CC P20618; Q58EX7: PLEKHG4; NbExp=3; IntAct=EBI-372273, EBI-949255;
CC P20618; Q9Y244: POMP; NbExp=3; IntAct=EBI-372273, EBI-696895;
CC P20618; P25786: PSMA1; NbExp=8; IntAct=EBI-372273, EBI-359352;
CC P20618; P49721: PSMB2; NbExp=3; IntAct=EBI-372273, EBI-359335;
CC P20618; P49720: PSMB3; NbExp=3; IntAct=EBI-372273, EBI-603340;
CC P20618; P28070: PSMB4; NbExp=6; IntAct=EBI-372273, EBI-603350;
CC P20618; P28074: PSMB5; NbExp=4; IntAct=EBI-372273, EBI-357828;
CC P20618; Q99436: PSMB7; NbExp=9; IntAct=EBI-372273, EBI-603319;
CC P20618; Q53H96: PYCR3; NbExp=3; IntAct=EBI-372273, EBI-2959680;
CC P20618; P57055: RIPPLY3; NbExp=3; IntAct=EBI-372273, EBI-12092053;
CC P20618; O76064: RNF8; NbExp=3; IntAct=EBI-372273, EBI-373337;
CC P20618; Q9NQG5: RPRD1B; NbExp=3; IntAct=EBI-372273, EBI-747925;
CC P20618; Q9UIY3: RWDD2A; NbExp=3; IntAct=EBI-372273, EBI-17677006;
CC P20618; Q8N488: RYBP; NbExp=3; IntAct=EBI-372273, EBI-752324;
CC P20618; Q6ZMJ2-2: SCARA5; NbExp=3; IntAct=EBI-372273, EBI-12823227;
CC P20618; Q99961: SH3GL1; NbExp=3; IntAct=EBI-372273, EBI-697911;
CC P20618; P84022: SMAD3; NbExp=3; IntAct=EBI-372273, EBI-347161;
CC P20618; Q12824-2: SMARCB1; NbExp=3; IntAct=EBI-372273, EBI-358436;
CC P20618; Q93045: STMN2; NbExp=3; IntAct=EBI-372273, EBI-714194;
CC P20618; P0C1Z6: TFPT; NbExp=3; IntAct=EBI-372273, EBI-1245626;
CC P20618; Q8TBB0: THAP6; NbExp=3; IntAct=EBI-372273, EBI-3925505;
CC P20618; Q08117-2: TLE5; NbExp=3; IntAct=EBI-372273, EBI-11741437;
CC P20618; Q9H0E2: TOLLIP; NbExp=3; IntAct=EBI-372273, EBI-74615;
CC P20618; Q13077: TRAF1; NbExp=7; IntAct=EBI-372273, EBI-359224;
CC P20618; Q12933: TRAF2; NbExp=5; IntAct=EBI-372273, EBI-355744;
CC P20618; P36406: TRIM23; NbExp=3; IntAct=EBI-372273, EBI-740098;
CC P20618; P14373: TRIM27; NbExp=8; IntAct=EBI-372273, EBI-719493;
CC P20618; Q9HCM9-2: TRIM39; NbExp=3; IntAct=EBI-372273, EBI-11523450;
CC P20618; Q6PID6: TTC33; NbExp=3; IntAct=EBI-372273, EBI-2555404;
CC P20618; Q8TF42: UBASH3B; NbExp=3; IntAct=EBI-372273, EBI-1380492;
CC P20618; Q5SQQ9-2: VAX1; NbExp=3; IntAct=EBI-372273, EBI-12227803;
CC P20618; O76024: WFS1; NbExp=3; IntAct=EBI-372273, EBI-720609;
CC P20618; P23025: XPA; NbExp=3; IntAct=EBI-372273, EBI-295222;
CC P20618; A0A0C4DGF1: ZBTB32; NbExp=3; IntAct=EBI-372273, EBI-10188476;
CC P20618; Q13360-2: ZNF177; NbExp=3; IntAct=EBI-372273, EBI-12272076;
CC P20618; Q7Z4V0: ZNF438; NbExp=3; IntAct=EBI-372273, EBI-11962468;
CC P20618; P0C7X2: ZNF688; NbExp=3; IntAct=EBI-372273, EBI-4395732;
CC P20618; Q6NX45: ZNF774; NbExp=3; IntAct=EBI-372273, EBI-10251462;
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12181345,
CC ECO:0000269|PubMed:34711951}. Nucleus {ECO:0000269|PubMed:12181345,
CC ECO:0000269|PubMed:34711951}. Note=Translocated from the cytoplasm into
CC the nucleus following interaction with AKIRIN2, which bridges the
CC proteasome with the nuclear import receptor IPO9.
CC {ECO:0000269|PubMed:34711951}.
CC -!- SIMILARITY: Belongs to the peptidase T1B family. {ECO:0000255|PROSITE-
CC ProRule:PRU00809}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; D00761; BAA00658.1; -; mRNA.
DR EMBL; BT019720; AAV38525.1; -; mRNA.
DR EMBL; AB451312; BAG70126.1; -; mRNA.
DR EMBL; AB451442; BAG70256.1; -; mRNA.
DR EMBL; AL031259; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR EMBL; BC000508; AAH00508.1; -; mRNA.
DR EMBL; BC020807; AAH20807.1; -; mRNA.
DR CCDS; CCDS34577.1; -.
DR PIR; S15973; SNHUC5.
DR RefSeq; NP_002784.1; NM_002793.3.
DR PDB; 4R3O; X-ray; 2.60 A; 1/M=29-241.
DR PDB; 4R67; X-ray; 2.89 A; 1/M/a/o=29-241.
DR PDB; 5A0Q; EM; 3.50 A; M/a=29-241.
DR PDB; 5GJQ; EM; 4.50 A; f/t=1-241.
DR PDB; 5GJR; EM; 3.50 A; f/t=1-241.
DR PDB; 5L4G; EM; 4.02 A; 1/U=1-241.
DR PDB; 5L5B; X-ray; 2.80 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L5D; X-ray; 2.80 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L5E; X-ray; 2.90 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L5F; X-ray; 2.50 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L5H; X-ray; 2.60 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L5I; X-ray; 2.90 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L5J; X-ray; 2.90 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L5O; X-ray; 2.60 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L5P; X-ray; 2.80 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L5Q; X-ray; 2.80 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L5R; X-ray; 2.90 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L5S; X-ray; 2.60 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L5T; X-ray; 2.90 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L5U; X-ray; 2.60 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L5V; X-ray; 2.70 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L5W; X-ray; 2.80 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L5X; X-ray; 2.90 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L5Y; X-ray; 2.70 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L5Z; X-ray; 2.70 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L60; X-ray; 2.70 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L61; X-ray; 2.80 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L62; X-ray; 2.80 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L63; X-ray; 2.70 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5L64; X-ray; 2.70 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5LE5; X-ray; 1.80 A; L/Z=29-241.
DR PDB; 5LEX; X-ray; 2.20 A; L/Z=29-241.
DR PDB; 5LEY; X-ray; 1.90 A; L/Z=29-241.
DR PDB; 5LEZ; X-ray; 2.19 A; L/Z=29-241.
DR PDB; 5LF0; X-ray; 2.41 A; L/Z=29-241.
DR PDB; 5LF1; X-ray; 2.00 A; L/Z=29-241.
DR PDB; 5LF3; X-ray; 2.10 A; L/Z=29-241.
DR PDB; 5LF4; X-ray; 1.99 A; L/Z=29-241.
DR PDB; 5LF6; X-ray; 2.07 A; L/Z=29-241.
DR PDB; 5LF7; X-ray; 2.00 A; L/Z=29-241.
DR PDB; 5LN3; EM; 6.80 A; 6=1-241.
DR PDB; 5M2B; X-ray; 2.70 A; L/Z=124-138, L/Z=145-160.
DR PDB; 5M32; EM; 3.80 A; L/Z=1-241.
DR PDB; 5T0C; EM; 3.80 A; AS/BS=2-241.
DR PDB; 5T0G; EM; 4.40 A; S=2-241.
DR PDB; 5T0H; EM; 6.80 A; S=2-241.
DR PDB; 5T0I; EM; 8.00 A; S=2-241.
DR PDB; 5T0J; EM; 8.00 A; S=2-241.
DR PDB; 5VFO; EM; 3.50 A; S/s=29-241.
DR PDB; 5VFP; EM; 4.20 A; S/s=29-241.
DR PDB; 5VFQ; EM; 4.20 A; S/s=29-241.
DR PDB; 5VFR; EM; 4.90 A; S/s=29-241.
DR PDB; 5VFS; EM; 3.60 A; S/s=29-241.
DR PDB; 5VFT; EM; 7.00 A; S/s=29-241.
DR PDB; 5VFU; EM; 5.80 A; S/s=29-241.
DR PDB; 6AVO; EM; 3.80 A; S/X=29-241.
DR PDB; 6E5B; X-ray; 2.77 A; L/Z=1-241.
DR PDB; 6KWY; EM; 2.72 A; L/Z=1-241.
DR PDB; 6MSB; EM; 3.00 A; S/s=2-241.
DR PDB; 6MSD; EM; 3.20 A; S/s=2-241.
DR PDB; 6MSE; EM; 3.30 A; A=151-231.
DR PDB; 6MSG; EM; 3.50 A; S/s=2-241.
DR PDB; 6MSH; EM; 3.60 A; S/s=2-241.
DR PDB; 6MSJ; EM; 3.30 A; S/s=2-241.
DR PDB; 6MSK; EM; 3.20 A; S/s=2-241.
DR PDB; 6R70; EM; 3.50 A; L/Z=29-241.
DR PDB; 6REY; EM; 3.00 A; M/a=29-241.
DR PDB; 6RGQ; EM; 2.60 A; M/a=29-241.
DR PDB; 6WJD; EM; 4.80 A; S/s=2-241.
DR PDB; 6WJN; EM; 5.70 A; S/s=29-241.
DR PDB; 6XMJ; EM; 3.00 A; M=29-241.
DR PDB; 7AWE; X-ray; 2.29 A; M/a=29-241.
DR PDB; 7B12; X-ray; 2.43 A; 1/M=29-241.
DR PDB; 7LXV; EM; 3.40 A; L/Z=29-241.
DR PDB; 7NHT; EM; 2.80 A; L=1-241.
DR PDB; 7PG9; EM; 3.70 A; M/a=29-241.
DR PDB; 7V5G; EM; 4.47 A; F/M=29-241.
DR PDB; 7V5M; EM; 3.88 A; M/a=29-241.
DR PDBsum; 4R3O; -.
DR PDBsum; 4R67; -.
DR PDBsum; 5A0Q; -.
DR PDBsum; 5GJQ; -.
DR PDBsum; 5GJR; -.
DR PDBsum; 5L4G; -.
DR PDBsum; 5L5B; -.
DR PDBsum; 5L5D; -.
DR PDBsum; 5L5E; -.
DR PDBsum; 5L5F; -.
DR PDBsum; 5L5H; -.
DR PDBsum; 5L5I; -.
DR PDBsum; 5L5J; -.
DR PDBsum; 5L5O; -.
DR PDBsum; 5L5P; -.
DR PDBsum; 5L5Q; -.
DR PDBsum; 5L5R; -.
DR PDBsum; 5L5S; -.
DR PDBsum; 5L5T; -.
DR PDBsum; 5L5U; -.
DR PDBsum; 5L5V; -.
DR PDBsum; 5L5W; -.
DR PDBsum; 5L5X; -.
DR PDBsum; 5L5Y; -.
DR PDBsum; 5L5Z; -.
DR PDBsum; 5L60; -.
DR PDBsum; 5L61; -.
DR PDBsum; 5L62; -.
DR PDBsum; 5L63; -.
DR PDBsum; 5L64; -.
DR PDBsum; 5LE5; -.
DR PDBsum; 5LEX; -.
DR PDBsum; 5LEY; -.
DR PDBsum; 5LEZ; -.
DR PDBsum; 5LF0; -.
DR PDBsum; 5LF1; -.
DR PDBsum; 5LF3; -.
DR PDBsum; 5LF4; -.
DR PDBsum; 5LF6; -.
DR PDBsum; 5LF7; -.
DR PDBsum; 5LN3; -.
DR PDBsum; 5M2B; -.
DR PDBsum; 5M32; -.
DR PDBsum; 5T0C; -.
DR PDBsum; 5T0G; -.
DR PDBsum; 5T0H; -.
DR PDBsum; 5T0I; -.
DR PDBsum; 5T0J; -.
DR PDBsum; 5VFO; -.
DR PDBsum; 5VFP; -.
DR PDBsum; 5VFQ; -.
DR PDBsum; 5VFR; -.
DR PDBsum; 5VFS; -.
DR PDBsum; 5VFT; -.
DR PDBsum; 5VFU; -.
DR PDBsum; 6AVO; -.
DR PDBsum; 6E5B; -.
DR PDBsum; 6KWY; -.
DR PDBsum; 6MSB; -.
DR PDBsum; 6MSD; -.
DR PDBsum; 6MSE; -.
DR PDBsum; 6MSG; -.
DR PDBsum; 6MSH; -.
DR PDBsum; 6MSJ; -.
DR PDBsum; 6MSK; -.
DR PDBsum; 6R70; -.
DR PDBsum; 6REY; -.
DR PDBsum; 6RGQ; -.
DR PDBsum; 6WJD; -.
DR PDBsum; 6WJN; -.
DR PDBsum; 6XMJ; -.
DR PDBsum; 7AWE; -.
DR PDBsum; 7B12; -.
DR PDBsum; 7LXV; -.
DR PDBsum; 7NHT; -.
DR PDBsum; 7PG9; -.
DR PDBsum; 7V5G; -.
DR PDBsum; 7V5M; -.
DR AlphaFoldDB; P20618; -.
DR SMR; P20618; -.
DR BioGRID; 111662; 284.
DR ComplexPortal; CPX-5993; 26S Proteasome complex.
DR CORUM; P20618; -.
DR DIP; DIP-31193N; -.
DR IntAct; P20618; 178.
DR MINT; P20618; -.
DR STRING; 9606.ENSP00000262193; -.
DR BindingDB; P20618; -.
DR ChEMBL; CHEMBL4208; -.
DR DrugBank; DB08515; (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE.
DR DrugBank; DB00188; Bortezomib.
DR DrugBank; DB08889; Carfilzomib.
DR DrugCentral; P20618; -.
DR GuidetoPHARMACOLOGY; 2404; -.
DR MEROPS; T01.986; -.
DR GlyGen; P20618; 2 sites.
DR iPTMnet; P20618; -.
DR MetOSite; P20618; -.
DR PhosphoSitePlus; P20618; -.
DR SwissPalm; P20618; -.
DR BioMuta; PSMB1; -.
DR DMDM; 130853; -.
DR REPRODUCTION-2DPAGE; IPI00025019; -.
DR UCD-2DPAGE; P20618; -.
DR EPD; P20618; -.
DR jPOST; P20618; -.
DR MassIVE; P20618; -.
DR MaxQB; P20618; -.
DR PaxDb; P20618; -.
DR PeptideAtlas; P20618; -.
DR PRIDE; P20618; -.
DR ProteomicsDB; 53768; -.
DR TopDownProteomics; P20618; -.
DR Antibodypedia; 33582; 238 antibodies from 32 providers.
DR DNASU; 5689; -.
DR Ensembl; ENST00000262193.7; ENSP00000262193.6; ENSG00000008018.9.
DR GeneID; 5689; -.
DR KEGG; hsa:5689; -.
DR MANE-Select; ENST00000262193.7; ENSP00000262193.6; NM_002793.4; NP_002784.1.
DR UCSC; uc011ehe.3; human.
DR CTD; 5689; -.
DR DisGeNET; 5689; -.
DR GeneCards; PSMB1; -.
DR HGNC; HGNC:9537; PSMB1.
DR HPA; ENSG00000008018; Low tissue specificity.
DR MIM; 602017; gene.
DR neXtProt; NX_P20618; -.
DR OpenTargets; ENSG00000008018; -.
DR PharmGKB; PA33882; -.
DR VEuPathDB; HostDB:ENSG00000008018; -.
DR eggNOG; KOG0179; Eukaryota.
DR GeneTree; ENSGT00550000075035; -.
DR HOGENOM; CLU_035750_1_1_1; -.
DR InParanoid; P20618; -.
DR OMA; IGFKNMQ; -.
DR OrthoDB; 1092660at2759; -.
DR PhylomeDB; P20618; -.
DR TreeFam; TF106218; -.
DR PathwayCommons; P20618; -.
DR Reactome; R-HSA-1169091; Activation of NF-kappaB in B cells.
DR Reactome; R-HSA-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR Reactome; R-HSA-1236978; Cross-presentation of soluble exogenous antigens (endosomes).
DR Reactome; R-HSA-174084; Autodegradation of Cdh1 by Cdh1:APC/C.
DR Reactome; R-HSA-174113; SCF-beta-TrCP mediated degradation of Emi1.
DR Reactome; R-HSA-174154; APC/C:Cdc20 mediated degradation of Securin.
DR Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR Reactome; R-HSA-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR Reactome; R-HSA-180534; Vpu mediated degradation of CD4.
DR Reactome; R-HSA-180585; Vif-mediated degradation of APOBEC3G.
DR Reactome; R-HSA-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
DR Reactome; R-HSA-202424; Downstream TCR signaling.
DR Reactome; R-HSA-211733; Regulation of activated PAK-2p34 by proteasome mediated degradation.
DR Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR Reactome; R-HSA-349425; Autodegradation of the E3 ubiquitin ligase COP1.
DR Reactome; R-HSA-350562; Regulation of ornithine decarboxylase (ODC).
DR Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR Reactome; R-HSA-4608870; Asymmetric localization of PCP proteins.
DR Reactome; R-HSA-4641257; Degradation of AXIN.
DR Reactome; R-HSA-4641258; Degradation of DVL.
DR Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR Reactome; R-HSA-5362768; Hh mutants are degraded by ERAD.
DR Reactome; R-HSA-5607761; Dectin-1 mediated noncanonical NF-kB signaling.
DR Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR Reactome; R-HSA-5668541; TNFR2 non-canonical NF-kB pathway.
DR Reactome; R-HSA-5676590; NIK-->noncanonical NF-kB signaling.
DR Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR Reactome; R-HSA-5689603; UCH proteinases.
DR Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR Reactome; R-HSA-6798695; Neutrophil degranulation.
DR Reactome; R-HSA-68867; Assembly of the pre-replicative complex.
DR Reactome; R-HSA-68949; Orc1 removal from chromatin.
DR Reactome; R-HSA-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR Reactome; R-HSA-69481; G2/M Checkpoints.
DR Reactome; R-HSA-69601; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A.
DR Reactome; R-HSA-75815; Ubiquitin-dependent degradation of Cyclin D.
DR Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR Reactome; R-HSA-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR Reactome; R-HSA-8941858; Regulation of RUNX3 expression and activity.
DR Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR Reactome; R-HSA-8951664; Neddylation.
DR Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR Reactome; R-HSA-9604323; Negative regulation of NOTCH4 signaling.
DR Reactome; R-HSA-9755511; KEAP1-NFE2L2 pathway.
DR Reactome; R-HSA-9762114; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2.
DR Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR SignaLink; P20618; -.
DR SIGNOR; P20618; -.
DR BioGRID-ORCS; 5689; 749 hits in 1092 CRISPR screens.
DR ChiTaRS; PSMB1; human.
DR GeneWiki; PSMB1; -.
DR GenomeRNAi; 5689; -.
DR Pharos; P20618; Tclin.
DR PRO; PR:P20618; -.
DR Proteomes; UP000005640; Chromosome 6.
DR RNAct; P20618; protein.
DR Bgee; ENSG00000008018; Expressed in gingival epithelium and 210 other tissues.
DR ExpressionAtlas; P20618; baseline and differential.
DR Genevisible; P20618; HS.
DR GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR GO; GO:0005829; C:cytosol; TAS:Reactome.
DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR GO; GO:0000502; C:proteasome complex; IDA:UniProtKB.
DR GO; GO:0005839; C:proteasome core complex; IDA:UniProtKB.
DR GO; GO:0019774; C:proteasome core complex, beta-subunit complex; ISS:UniProtKB.
DR GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR GO; GO:0010498; P:proteasomal protein catabolic process; IBA:GO_Central.
DR GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IC:ComplexPortal.
DR Gene3D; 3.60.20.10; -; 1.
DR InterPro; IPR029055; Ntn_hydrolases_N.
DR InterPro; IPR035202; Proteasome_beta1.
DR InterPro; IPR016050; Proteasome_bsu_CS.
DR InterPro; IPR001353; Proteasome_sua/b.
DR InterPro; IPR023333; Proteasome_suB-type.
DR PANTHER; PTHR11599:SF59; PTHR11599:SF59; 1.
DR Pfam; PF00227; Proteasome; 1.
DR SUPFAM; SSF56235; SSF56235; 1.
DR PROSITE; PS00854; PROTEASOME_BETA_1; 1.
DR PROSITE; PS51476; PROTEASOME_BETA_2; 1.
PE 1: Evidence at protein level;
KW 3D-structure; Acetylation; Cytoplasm; Direct protein sequencing;
KW Glycoprotein; Host-virus interaction; Nucleus; Phosphoprotein; Proteasome;
KW Reference proteome.
FT PROPEP 1..28
FT /evidence="ECO:0000269|PubMed:2306472"
FT /id="PRO_0000259623"
FT CHAIN 29..241
FT /note="Proteasome subunit beta type-1"
FT /id="PRO_0000148030"
FT MOD_RES 1
FT /note="N-acetylmethionine"
FT /evidence="ECO:0007744|PubMed:22814378"
FT MOD_RES 62
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:23186163"
FT MOD_RES 68
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:23186163"
FT MOD_RES 150
FT /note="Phosphotyrosine"
FT /evidence="ECO:0000250|UniProtKB:O09061"
FT MOD_RES 162
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:23186163"
FT MOD_RES 204
FT /note="N6-acetyllysine"
FT /evidence="ECO:0007744|PubMed:19608861"
FT CARBOHYD 58
FT /note="O-linked (GlcNAc) serine"
FT /evidence="ECO:0000250"
FT CARBOHYD 209
FT /note="O-linked (GlcNAc) serine"
FT /evidence="ECO:0000250"
FT VARIANT 11
FT /note="P -> A (in dbSNP:rs12717)"
FT /evidence="ECO:0000269|PubMed:15489334"
FT /id="VAR_051547"
FT VARIANT 208
FT /note="I -> N (in dbSNP:rs10541)"
FT /id="VAR_051548"
FT STRAND 39..44
FT /evidence="ECO:0007829|PDB:5LE5"
FT STRAND 49..54
FT /evidence="ECO:0007829|PDB:5LE5"
FT STRAND 57..59
FT /evidence="ECO:0007829|PDB:5LE5"
FT STRAND 62..66
FT /evidence="ECO:0007829|PDB:5LE5"
FT STRAND 71..75
FT /evidence="ECO:0007829|PDB:5LE5"
FT STRAND 78..84
FT /evidence="ECO:0007829|PDB:5LE5"
FT HELIX 86..107
FT /evidence="ECO:0007829|PDB:5LE5"
FT HELIX 113..126
FT /evidence="ECO:0007829|PDB:5LE5"
FT TURN 127..129
FT /evidence="ECO:0007829|PDB:5LE5"
FT STRAND 134..141
FT /evidence="ECO:0007829|PDB:5LE5"
FT STRAND 143..145
FT /evidence="ECO:0007829|PDB:5VFO"
FT STRAND 147..152
FT /evidence="ECO:0007829|PDB:5LE5"
FT STRAND 154..156
FT /evidence="ECO:0007829|PDB:5VFO"
FT STRAND 158..167
FT /evidence="ECO:0007829|PDB:5LE5"
FT HELIX 170..180
FT /evidence="ECO:0007829|PDB:5LE5"
FT HELIX 196..213
FT /evidence="ECO:0007829|PDB:5LE5"
FT STRAND 214..217
FT /evidence="ECO:0007829|PDB:4R3O"
FT STRAND 219..227
FT /evidence="ECO:0007829|PDB:5LE5"
FT STRAND 230..237
FT /evidence="ECO:0007829|PDB:5LE5"
SQ SEQUENCE 241 AA; 26489 MW; AE8FC42799F39157 CRC64;
MLSSTAMYSA PGRDLGMEPH RAAGPLQLRF SPYVFNGGTI LAIAGEDFAI VASDTRLSEG
FSIHTRDSPK CYKLTDKTVI GCSGFHGDCL TLTKIIEARL KMYKHSNNKA MTTGAIAAML
STILYSRRFF PYYVYNIIGG LDEEGKGAVY SFDPVGSYQR DSFKAGGSAS AMLQPLLDNQ
VGFKNMQNVE HVPLSLDRAM RLVKDVFISA AERDVYTGDA LRICIVTKEG IREETVSLRK
D
